{"DataElement":{"publicId":"2558","version":"3","preferredName":"Colorectal Tumor Pathologic N Stage","preferredDefinition":"an extent of nodal involvement before treatment determined by review of removed regional lymph nodes to evaluate the highest category of nodes involved and to rule out regional lymph node metastasis.","longName":"COLOREC_TUMOR_P_N_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2189084","version":"1","preferredName":"Colorectal Tumor Pathologic N Stage","preferredDefinition":"Information related to pathologic N stage of a colorectal tumor.","longName":"COLORECT_TUMOR_P_N","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206583","version":"1","preferredName":"Colorectal Neoplasm","preferredDefinition":"(ko-lo-REK-tul) Having to do with the colon or the rectum.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C13363:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal","conceptCode":"C13363","definition":"Relating to the colon and rectum, or to the entire large bowel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FAFA-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E109AF-FC5C-4E01-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-07","modifiedBy":"TAYLORT","dateModified":"2019-08-28","changeDescription":"8-28-19 ownership transfer approved by CTEP/B.Campbell; tmt. Updated to use Property based on NCIt concepts","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018465","version":"1","preferredName":"Colorectal Tumor N Stage","preferredDefinition":"the N (nodal) stage of a colorectal tumor.","longName":"COLOREC_TUMOR_N_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N0","valueDescription":"NO REGIONAL LYMPH NODE METASTASIS","ValueMeaning":{"publicId":"2559539","version":"1","preferredName":"NO REGIONAL LYMPH NODE METASTASIS","longName":"2559539","preferredDefinition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN0 TNM Finding v6 and v7","conceptCode":"C73347","definition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5A0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MAESKEB","dateModified":"2018-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5DC4102-F77B-5229-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"N1","valueDescription":"METASTASIS IN 1 TO 3 REGIONAL LYMPH NODES","ValueMeaning":{"publicId":"2559180","version":"1","preferredName":"METASTASIS IN 1 TO 3 REGIONAL LYMPH NODES","longName":"2559180","preferredDefinition":"METASTASIS IN 1 TO 3 REGIONAL LYMPH NODES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B439-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5DC4102-F77D-5229-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"N2","valueDescription":"METASTASIS IN 4 OR MORE REGIONAL LYMPH NODES","ValueMeaning":{"publicId":"2559181","version":"1","preferredName":"METASTASIS IN 4 OR MORE REGIONAL LYMPH NODES","longName":"2559181","preferredDefinition":"METASTASIS IN 4 OR MORE REGIONAL LYMPH NODES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B43A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5DC4102-F77F-5229-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"NX","valueDescription":"REGIONAL LYMPH NODE CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2559960","version":"1","preferredName":"REGIONAL LYMPH NODE CANNOT BE ASSESSED","longName":"2559960","preferredDefinition":"REGIONAL LYMPH NODE CANNOT BE ASSESSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B745-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MAESKEB","dateModified":"2018-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5DC4102-F781-5229-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-04","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B44B9E81-9E4D-4B70-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-15","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-15","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811933","version":"1","longName":"Pathology Colorectal","context":"CTEP"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2813054","version":"1","longName":"St. Joseph Hospital","context":"NCIP"},{"publicId":"2813090","version":"1","longName":"SJO_ERCC1_07035","context":"NCIP"}]},{"publicId":"2716207","version":"1","longName":"ASCO (American Society of Clinical Oncology)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812709","version":"1","longName":"Colon Adjuvant Treatment Summary","context":"NCIP"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"COMMENT_232","type":"COMMENT","description":"Instruction on template form: Note: Nodes should count discrete extramural deposits plus positive lymph nodes.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"N Stage, Pathologic","url":null,"context":"CTEP"},{"name":"Pathologic N Stage","type":"Preferred Question Text","description":"Pathologic N Stage","url":null,"context":"CTEP"},{"name":"Source","type":"DATA_ELEMENT_SOURCE","description":"AJCC Cancer Staging Manual, 6th Edition","url":null,"context":"CTEP"},{"name":"N Stage","type":"Alternate Question Text","description":"N Stage","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B45F5196-E33F-00F3-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-16","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-16","modifiedBy":"REEVESD","dateModified":"2011-04-19","changeDescription":"ISO 11179 Compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}